| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | HG-6-64-1 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.003 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.16 | 0.004 |
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.004 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.1 | 0.004 |
| mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | -0.092 | 0.004 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.17 | 0.005 |
| mRNA | PIK-93 | GDSC1000 | pan-cancer | AAC | -0.084 | 0.005 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.005 |
| mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | 0.1 | 0.005 |
| mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | 0.1 | 0.005 |